23and me stock.

Nov 29, 2023 · What is 23andMe's consensus rating and price target? According to the issued ratings of 1 analysts in the last year, the consensus rating for 23andMe stock is Buy based on the current 1 buy rating for ME. The average twelve-month price prediction for 23andMe is $1.75 with a high price target of $1.75 and a low price target of $1.75. Q3 2024 EPS Estimate Trends. Current. -$0.15. 1 Month Ago. -$0.15. 3 Months Ago. -$0.18. 23andMe Holding Co. analyst estimates, including ME earnings per share estimates and analyst recommendations.25 de set. de 2023 ... Anne Wojcicki and her co-founders started 23andMe back in 2006 with a clear mission: to make genetic testing and its results, ...23andMe Holding Co. Class A Common Stock. P/E & PEG Ratios. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market ...Majority of impacted users are now being notified, 23andMe confirmed. It's now been confirmed that an additional 6.9 million 23andMe users had ancestry data …

See 23andMe Holding Co. (ME) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.23andMe’s stock closed down more than 1% percent at $0.86 Friday, continuing a downward trend that first started in October 2021, when the company’s stock was trading at more than $11 per ...Shares of 23andMe Holding Co. ME, -1.39% jumped 23% in the extended session Thursday after the genetics and biopharmaceutical company said that the U.S. Food and Drug Administration has cleared it ...

23andMe, the consumer genetics company that popularized at home DNA test kits, is going public via merger with a SPAC. The company will merge with Richard Branson's VG Acquisition Corp. in a deal ...

Nov 30, 2023 · According to 3 analysts, the average rating for ME stock is "Strong Buy." The 12-month stock price forecast is $4.92, which is an increase of 455.87% from the latest price. 23andMe to Report FY2024 Second Quarter Financial Results. SOUTH SAN FRANCISCO, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report ...NEW YORK, NY / ACCESSWIRE / December 4, 2023 / 23andMe, a popular personal genomics and DNA analysis company run by 23andMe Holding Co. …Achieved FY2022 financial guidance. Fourth quarter and full year revenues of $101 million and $272 million representing 14% and 11% increases over prior year, respectively. New genomic health services expected in FY2023. Webcast today, May 26, 2022, at 4:30 p.m. Eastern Time.Nov 30, 2023 · Complete 23andMe Holding Co. stock information by Barron's. View real-time ME stock price and news, along with industry-best analysis.

23andMe to Report FY2024 Second Quarter Financial Results. SOUTH SAN FRANCISCO, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced …

23andMe Holding Co. analyst ratings, historical stock prices, earnings estimates & actuals. ME updated stock price target summary.

The transaction will value the outstanding shares of capital stock of 23andMe at an aggregate enterprise value of approximately $3.5 billion. 23andMe CEO and Co-Founder Anne Wojcicki and Virgin Group’s Richard Branson are each investing $25 million into the $250 million PIPE and are joined by leading institutional investors including …The transaction will value the outstanding shares of capital stock of 23andMe at an aggregate enterprise value of approximately $3.5 billion ; 23andMe CEO and Co-Founder Anne Wojcicki and Virgin Group’s Sir Richard Branson are each investing $25 million into the $250 million PIPE and are joined by leading institutional investors …23andMe saw a increase in short interest in October. As of October 31st, there was short interest totaling 26,900,000 shares, an increase of 0.4% from the previous total of 26,800,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price ...See the company profile for 23andMe Holding Co. (ME) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...I understand that I may withdraw my consent and unsubscribe at any time. Get two Health + Ancestry Services for $239; third Health + Ancestry Service is $129; each additional Health + Ancestry Service is $299. Offer ends Nov 27. Entry of your email address is not necessary to redeem the offer. Shop now. Limit 3.The 23andMe Holding stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Webcast at 4:30 pm ET, August 8, 2023. SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical ...By Samuel O'Brient, InvestorPlace Financial News Writer Aug 19, 2022, 11:42 am EST. 23andMe ( ME) stock is falling today on major executive shift news. CFO Steven Schoch will be stepping down from ...Under the merger agreement, the purchase price is $400 million (subject to certain customary downward adjustments), of which 25% will be paid in cash and 75% in shares of 23andMe Class A Common Stock.Jun 24, 2021 · In 2019, the company brought in $441 million in revenue, with consumer services accounting for 96% of sales. However, its forecast for this year amounts to just $243.5 million in sales. 23andMe is ... See 23andMe Holding Co. (ME) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

SUNNYVALE, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, today announced that it has completed its ...Nov 30, 2023 · A. The latest price target for 23andMe Holding ( NASDAQ: ME) was reported by Citigroup on Thursday, August 10, 2023. The analyst firm set a price target for 1.75 expecting ME to rise to within 12 ...

Stock Quote & Chart | 23andMe, Inc. Stock Quote & Chart Change Volume Today's Open Previous Close Today's High Today's Low 52 Week High 52 Week Low IFF Technical Analysis Tools & Settings Open High Low Close Volume Volume remove 1DY | 5DY | 1M | 3M | 6M | YTD | 1Y | 5Y | 10Y | Max | Custom Data Provided by Refinitiv. Minimum 15 minutes delayed.6 de set. de 2023 ... 23andMe Holding Co. (ME) stock is down -66.15% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.Under the merger agreement, the purchase price is $400 million (subject to certain customary downward adjustments), of which 25% will be paid in cash and 75% in shares of 23andMe Class A Common Stock.Compare 23andMe DNA Test Kits - Which one is the best for you? Special Bundle Offer: Get two Health + Ancestry Services for $199. Get two Health + Ancestry Services for $199; third Health + Ancestry Service is $109; each additional Health + Ancestry Service is $229. Offer ends Dec 4. Which service do you want.The 23andMe IPO price was $10 per share which is typical for SPACs, and the 23andMe IPO date was chosen to be June 17. The combined company was renamed to 23andMe Holding Co. and began trading on the Nasdaq stock market under the ticker symbol “ME”. The stock rose to $13.32 at the end of the day, which is +30% upside to …ME. +6.60%. Shares of 23andMe Holding Co. ME rallied more than 12% in the extended session Wednesday after the genetics company raised guidance for 2023. 23andMe lost $92 million, or 20 cents a ... According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.23andMe Holding Co. analyst ratings, historical stock prices, earnings estimates & actuals. ME updated stock price target summary.

23andMe is known for its ancestry DNA genetic testing service, but the company faces disruption from whole genome sequencing. Read why I rate ME stock a sell.

23andMe Holding Co. Stock Forecast. All Analysts Top Analysts ME's stock price has decreased by -72.45% in the past year and price targets may not have had time to catch up. Stock Price Forecast. According to 3 stock analysts, the average 12-month stock price forecast for ME stock stock is $4.92, which predicts an increase of 451.26%. The ...

Jun 17, 2021 · Shares of 23andMe ( ME) rose 21% to close at $13.32 apiece in their trading debut on the Nasdaq as the consumer genetic testing company became one of the latest companies to go public via SPAC ... Dec 4, 2023 11:59 AM PST. By Jon Swartz. Company says it believes breach was the result of customers recycling passwords. DNA-testing company 23andMe confirmed Monday that information about 6.9 ...DNA Genetic Testing For Health, Ancestry And More - 23andMe. Special Bundle Offer: Enter your email to unlock two Health + Ancestry Services for $199. Get two Health + Ancestry Services for $199; third Health + Ancestry Service is $109; each additional Health + Ancestry Service is $229. Offer ends Dec 4. Entry of your email address is not ...April 19, 2023 at 8:57 AM · 3 min read. When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales ratios (or "P/S") below 1.2x, 23andMe ...Nov 15, 2021 · Things got even worse today, when investors responded to a downgrade of 23andMe stock by a Citigroup analyst -- by selling off the stock by 10.1% (as of 11:30 a.m. EST). Image source: Getty Images ... Majority of impacted users are now being notified, 23andMe confirmed. It's now been confirmed that an additional 6.9 million 23andMe users had ancestry data …ME | 28 minutes ago. NEW YORK, NY / ACCESSWIRE / December 4, 2023 / 23andMe, a popular personal genomics and DNA analysis company run by 23andMe Holding Co. ("23 and Me") (NASDAQ:ME), recently suffered a massive data leak. The attack targeted the personal information of 23andMe users -more than 4 million people- compromising individual's ...Consumer-Driven Healthcare Data Finance Genomics. 23andMe is merging with VG Acquisition Corp., a special purpose acquisition company founded by billionaire Richard Branson, to go public. The deal ...23andMe, Inc. SUNNYVALE, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that it will ...The 23andMe IPO will proceed using the increasingly popular SPAC approach, and the deal is expected to be finalized in the Q2 of 2021. The company, as a result of going to market, will hold a $3.5 billion valuation. Meanwhile, 81% of the company’s shares will be owned by current shareholders, and both Branson and 23andMe Co-Founder and CEO ...Q4 Earnings Releases. 23andMe's FY2023 4th Quarter Earnings Call. 23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results. Form 10-K.By Bret Kenwell, InvestorPlace Contributor Aug 11, 2022, 3:12 pm EST. 23andMe ( ME) stock has more than doubled so far this month, with shares up 127% at today’s high from the July 29 low ...

Q4 Earnings Releases. 23andMe's FY2023 4th Quarter Earnings Call. 23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results. Form 10-K.FY2022 First Quarter Financial Results. Total revenue was $59 million for the quarter ended June 30, 2021, representing an increase of $11 million or 23%, year over year. This revenue growth was primarily due to higher Personal Genome Service (PGS) kit sales, which resulted from increased marketing spending and growth in consumer demand.23andMe Holding Co. Class A Common Stock. P/E & PEG Ratios. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market ...2 Wall Street research analysts have issued 1-year price objectives for 23andMe's shares. Their ME share price targets range from $1.75 to $7.00. On average, they anticipate the company's stock price to reach $4.38 in the next year. This suggests a possible upside of 381.4% from the stock's current price.Instagram:https://instagram. shorted stocks listis smartasset legitpaper trade optionsvanguard reit dividend msn.com - November 23 at 5:36 PM. Make Empowered Decisions with 23andMe Health + Ancestry Service, 57% Off for Black Friday. msn.com - November 21 at 1:15 PM. 23andMe and AncestryDNA kits are nearly half-off on Amazon Canada for Black Friday. uk.news.yahoo.com - November 20 at 7:52 PM. qqq price targethow to invest in lithium etf Oct 17, 2021 · In June, 23andMe ( ME 2.88%) officially finished the process of going public via a special purpose acquisition company ( SPAC ). These investment vehicles were popular in early 2021, but many have ... Dec 4, 2023, 9:49 PM UTC|. Image: Getty. 23andMe confirmed that a recent breach leaked data belonging to 6.9 million users. In an emailed statement to The Verge, company … best tech stocks 2023 Created with Highstock 2.1.8. 23andMe Holding Co. Annual stock financials by MarketWatch. View the latest ME financial statements, income statements and financial ratios.Find out the direct holders, institutional holders and mutual fund holders for 23andMe Holding Co. (ME).